Open AccessLive birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience
Author(s) -
Anne Mayeur,
Vincent Puy,
Victoria Windal,
Laëtitia Hesters,
V. Gallot,
A. Benoit,
Michaël Grynberg,
Charlotte Sonigo,
Nelly Frydman
Publication year - 2021
Publication title -
journal of assisted reproduction and genetics
Language(s) - English
Resource type - Journals
eISSN - 1573-7330
pISSN - 1058-0468
DOI - 10.1007/s10815-021-02168-3
Subject(s) - fertility preservation , cryopreservation , embryo cryopreservation , embryo transfer , in vitro fertilisation , live birth , oocyte cryopreservation , medicine , gynecology , embryo , retrospective cohort study , ovarian tissue cryopreservation , andrology , reproductive medicine , cancer , obstetrics , pregnancy , biology , fertility , surgery , population , genetics , environmental health , microbiology and biotechnology
The aim of this study was to evaluate the outcomes of frozen oocytes or embryos cryopreserved after controlled ovarian stimulation (COS) or in vitro maturation (IVM) for female cancer patients who underwent a fertility preservation (FP) prior to gonadotoxic therapy.